Michael Atkinson
Psychiatric/Mental Health · Farmingville, NYNPI 1386017747
Payments from drug & device makers
Across 242 payments — averaging $21.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$917
- Otsuka America Pharmaceutical, Inc.$735
- Takeda Pharmaceuticals U.S.A., Inc.$632
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$550
- Johnson & Johnson$535
- Corium, LLC$372
- plus $2K from 14 others
What the payments were for
- Food & beverage$5,253100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $917 |
| Otsuka America Pharmaceutical, Inc. | 33 | $735 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $632 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $550 |
| Johnson & Johnson | 19 | $535 |
| Corium, LLC | 24 | $372 |
| Lundbeck LLC | 16 | $271 |
| Alkermes, Inc. | 8 | $247 |
| Axsome Therapeutics, Inc. | 7 | $234 |
| Tris Pharma Inc | 10 | $190 |
| Vanda Pharmaceuticals Inc. | 4 | $96 |
| Supernus Pharmaceuticals, Inc. | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| E.r. Squibb & Sons, L.L.C. | 4 | $69 |
| Idorsia Pharmaceuticals US Inc | 3 | $64 |
| Neos Therapeutics, LP | 4 | $63 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Neurocrine Biosciences, Inc. | 1 | $33 |
| Biogen | 1 | $27 |
| Bausch Health US, LLC | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$468
- ABILIFY ASIMTUFII$250
- ABILIFY MAINTENA$250
- CAPLYTA$130
- VRAYLAR$125
- Auvelity$121
- ARISTADA INITIO$117
- REXULTI$112
How this compares
$5,253 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 11 | $23,554 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Farmingville
- Glenn HannDansville$1.3M
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Mary OlsonNew York$142K
- Elijah StevensBinghamton$131K
- Kayanna JonasFar Rockaway$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.